The Ensign Group, Inc.

ENSG Healthcare Medical Care Facilities

The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024. In the quarter to June 2026, revenue grew 17.3%, EPS grew 16.2%, free cash flow grew 12.2% and total debt fell 2.77%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for five.

176.63 1.48 −0.83%
Market cap
$10.4B
P/E
26.9×
Fwd P/E
24.1×
Dividend yield
0.15%
F-score
7/9
Altman Z
3.57
Beneish M
−2.57
Dividend safety
92/100

Insider Decisions trades per month

Total sells 13.59
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell 7 3 2 7 1 3 1 1 3 — — —
Insider Ownership 3.05%

Capital & Financial Ratios $m

Market Cap 10,380.00
Revenue 5,486.71
Net Income 379.04
Free Cash Flow 419.09
Net Debt (181.10)
Current Ratio 1.21
Debt/Equity 0.06 (at or below 0.5: strong)
P/E ratio 26.88
Fwd P/E 24.10
P/S ratio 1.87
P/B ratio 4.19
Past 5Y EPS Growth 13.80%
This Y EPS Growth 18.90% (at or above 15%: strong)
Next Y EPS Growth 9.90%
Next Y revenue growth 16.75% (at or above 10%: strong)
Next 5Y EPS Growth 12.74%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 73.13%
10-year low 10-year high
P/S against its own 10 years 82.01%
10-year low 10-year high
P/B against its own 10 years 62.48%
10-year low 10-year high
EV/Sales against its own 10 years 83.04%
10-year low 10-year high
EV/FCF against its own 10 years 57.70%
10-year low 10-year high

Dividends

Payout Ratio 0.04
Annual Dividend Rate 0.26
Annual Dividend Yield 0.15%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 0.27
0.07
0.07
0.07
2025 0.25
0.06
0.06
0.06
0.07
2024 0.24
0.06
0.06
0.06
0.06
2023 0.23
0.06
0.06
0.06
0.06
2022 0.22
0.06
0.06
0.06
0.06
2021 2.51
0.05
0.05
2.30
0.05
0.06
2020 0.20
0.05
0.05
0.05
0.05
2019 0.18
0.04
0.04
0.04
0.05
2018 0.17
0.04
0.04
0.04
0.04
2017 0.16
0.04
0.04
0.04
0.04
2016 0.15
0.04
0.04
0.04
0.04
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 527 527 572 321
Receivables 485 570 637 669
Inventory — — — —
Other — — — —
1,047 1,158 1,272 1,071
2023 2024 2025 Q'26
Payables 93 99 97 120
ST’ Debt 4 4 4 4
Other — — — —
735 743 894 885

Compound Annual Growth %

10y 5y 3y
Sales 14.19% 16.05% 18.68%
Cash Flow 32.68% 8.61% 27.46%
Earnings 20.03% 15.07% 15.25%
Book Value 18.00% 22.26% 21.41%

Revenue $m

Mar Jun Sep Dec Year
’26 1,389 1,440 — — —
’25 1,173 1,228 1,296 1,361 5,058
’24 1,010 1,036 1,082 1,132 4,260
’23 887 921 941 980 3,729
’22 713 732 770 810 3,025
’21 627 639 669 693 2,627
’20 590 585 599 629 2,403
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 100 172 — — —
’25 72 156 153 183 564
’24 35 77 134 100 347
’23 48 120 123 85 377
’22 46 84 93 50 273
’21 34 74 96 71 276
’20 27 147 108 91 373
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 65 119 — — —
’25 29 106 102 133 371
’24 6 42 92 49 189
’23 22 95 98 56 270
’22 30 70 71 22 194
’21 20 56 80 53 208
’20 11 136 97 79 323
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 1.67 1.68 — — —
’25 1.37 1.44 1.42 1.61 5.84
’24 1.19 1.22 1.34 1.36 5.12
’23 1.05 1.12 1.11 0.38 3.65
’22 0.89 1.01 0.99 1.06 3.95
’21 0.86 0.87 0.83 0.86 3.42
’20 0.73 0.73 0.77 0.82 3.06
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.4
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 16.46 15.44 20.27 34.89 24.06 68.29 70.29 85.50 110.71 118.73

Analyst estimates 2026–2028

Powerpack
High 22.32 23.18 45.80 58.93 77.27 98.66 97.42 115.11 158.45 194.00
People
People Employees 19,482 21,301 23,463 24,500 24,400 25,900 29,900 35,300 39,300 46,000
Revenue/emp, $m 0.08 0.08 0.07 0.08 0.10 0.10 0.10 0.11 0.11 0.11
Income, $m
Income, $m Revenue 1,655 1,598 1,755 2,037 2,403 2,627 3,025 3,729 4,260 5,058
Gross margin, % 11.39 10.82 12.46 14.29 16.96 17.82 17.12 15.84 15.67 15.81
EBT 86 31 72 116 218 258 289 273 386 456
EBT margin, % 5.19 1.95 4.09 5.70 9.06 9.82 9.56 7.31 9.06 9.01
Net income 53 41 93 112 171 198 225 210 298 344
Depreciation 40 43 45 52 55 57 63 73 85 105
Per share, $
Per share, $ Revenue 32.73 31.38 33.73 38.10 44.96 48.22 55.12 66.94 75.20 88.26
Earnings 0.99 0.79 1.78 2.07 3.19 3.57 4.09 3.76 5.26 6.00
Cash flow 1.46 1.56 4.04 3.60 6.99 5.06 4.97 6.76 6.13 9.85
Capex (0.49) (1.01) (0.89) (1.20) (0.93) (1.24) (1.44) (1.91) (2.79) (3.38)
Free cash flow 0.98 0.55 3.16 2.40 6.05 3.82 3.53 4.86 3.34 6.47
Book value 9.11 9.82 11.58 12.28 15.31 18.75 22.75 26.88 32.48 39.00
Shares, m 51 51 52 53 53 54 55 56 57 57
Valuation, ×
Valuation, × P/E 21.15 27.26 20.50 21.92 22.86 23.45 23.11 30.49 25.26 28.99
P/S 0.64 0.70 1.08 1.19 1.62 1.74 1.71 1.71 1.77 1.97
P/B 2.30 2.22 3.13 3.70 4.76 4.48 4.15 4.27 4.09 4.47
EV/Sales 0.77 0.86 1.19 1.31 1.57 1.70 1.66 1.61 1.68 1.89
EV/FCF 25.81 48.68 12.74 20.89 11.63 21.42 25.87 22.22 37.82 25.77
Cash, $m
Cash, $m Operating cash flow 74 80 210 192 373 276 273 377 347 564
Capex (25) (51) (46) (64) (50) (68) (79) (106) (158) (194)
Free cash flow 49 28 164 128 323 208 194 270 189 371
Balance, $m
Balance, $m Working capital 122 142 79 68 21 117 199 312 414 378
Total debt 284 313 243 328 116 157 153 149 146 142
Net debt 214 258 204 251 (135) (119) (179) (377) (381) (431)
Shareholders’ equity 460 500 602 656 818 1,022 1,249 1,497 1,840 2,235
Returns, %
Returns, % ROA 5.72 3.85 8.09 6.24 6.95 7.21 7.13 5.49 6.74 6.79
ROIC 8.51 3.56 6.59 8.90 20.40 18.04 17.33 14.25 15.35 14.73
ROE 11.27 8.43 16.76 17.57 23.13 21.16 19.79 15.25 17.85 16.88
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

The Ensign Group, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
THC Tenet Healthcare Corporation $22.2B 10.3× 6.4× +14.61% (above 0%: growing) +212.97% (above 0%: growing) −43.88% (below 0%: shrinking) 46.78% 24.85% Compare
EHC Encompass Health Corporation $12.6B 20.6× 16.8× +9.58% (above 0%: growing) +9.93% (above 0%: growing) −45.01% (below 0%: shrinking) 100.00% 17.85% Compare
DVA DaVita Inc. $12.1B 15.0× 13.1× +5.17% (above 0%: growing) +56.49% (above 0%: growing) +49.36% (above 0%: growing) 32.70% 16.29% Compare
FMS Fresenius Medical Care AG & Co. KGaA $11.8B 11.5× 12.5× +3.89% (above 0%: growing) +6.82% (above 0%: growing) +1.57% (above 0%: growing) 26.95% 9.58% Compare
UHS Universal Health Services, Inc. $11.0B 7.5× 6.1× +8.27% (above 0%: growing) +9.47% (above 0%: growing) −23.78% (below 0%: shrinking) 90.87% 11.14% Compare
ENSG The Ensign Group, Inc. $10.4B 26.9× 24.1× +17.33% (above 0%: growing) +16.22% (above 0%: growing) +12.24% (above 0%: growing) 16.65% 8.50%
PACS PACS Group, Inc. $7.6B 27.6× 16.8× +9.07% (above 0%: growing) +45.45% (above 0%: growing) +220.51% (above 0%: growing) 17.07% 7.66% Compare
CHE Chemed Corporation $6.7B 25.7× 20.4× +8.80% (above 0%: growing) +42.78% (above 0%: growing) −43.51% (below 0%: shrinking) 32.90% 13.25% Compare
CON Concentra Group Holdings Parent, Inc. $5.0B 24.9× 17.0× +10.03% (above 0%: growing) +45.71% (above 0%: growing) +91.62% (above 0%: growing) 31.70% 18.99% Compare
Median of peers $11.4B 17.8× 15.0× +8.94% +44.12% −11.11% 32.80% 14.77%

All 55 Medical Care Facilities stocks →

The Ensign Group, Inc. (ENSG) key facts

  • Strength: The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.
  • Strength: Net income was $344.3 million, or $6.00 per share (basic), a net margin of 6.80%.
  • The Ensign Group, Inc. (ENSG) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, ENSG traded at $176.63, a market capitalization of $10.4 billion.
  • At that price the stock trades at 26.9× trailing-twelve-month earnings and 1.9× sales; its P/E is higher than 73% of its own readings over the past ten years.
  • The Ensign Group, Inc. pays an annual dividend of $0.26 per share, a yield of 0.15%, with a payout ratio of 4.08%.
  • Return on equity was 16.9% and debt-to-equity 0.06.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 3.57 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

The Ensign Group, Inc. (ENSG) Latest News

stockrow.com/ENSG · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com